ono 1078 has been researched along with Polycystic Kidney Diseases in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pathomthongtaweechai, N | 1 |
| Soodvilai, S | 1 |
| Chatsudthipong, V | 1 |
| Muanprasat, C | 1 |
1 other study available for ono 1078 and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cell Survival; Chlorides; Chromones; Col | 2014 |